HymonBio has provided their high-quality SARS-CoV-2 Test Kit for the global fight against the COVID-19 pandemic. Once again, it has received another certification; this time, in Indonesia. This is a new market expansion after obtaining the US FDA EUA, EU CE, and Myanmar FDA.
The HymonBio® SARS-CoV-2 Test Kit, developed independently, has obtained Indonesian certification, indicating that it meets the requirements dictated by the application process and authorities. This is the first step to opening the Indonesian market. Simultaneously, it provides quality assurance for the sales of products in the domestic market and enhances the influence of our products.
Advantages of SARS-CoV-2 Test Kit
☆Received the FDA EUA certification, and cited by the FDA commissioner.
☆Rapid detection: Innovative and exclusive one-step method completes RNA processing in 3 minutes, with sample-to-resultsin 35 minutes.
☆Multiple monitoring: The original DIDC double internal standard technology carries out the entire process of quality controlof the sample quality and testing.
☆Unique technology: Nanobody molecular locking technology (MoLock) improves sensitivity and specificity.
☆Passed quality evaluation of many clinical institutions, including: American Reference Laboratory, Kenya NationalLaboratory, Shanghai Clinical Testing Center, Jiangsu Medical Device Inspection Institute, etc.
Mutations and variants continue to emerge from the COVID-19 pandemic, and it is still in an important stage of prevention and control. Timely and accurate diagnosis can effectively control spread. HymonBio will continue to provide accurate and abundant new detection kits for international epidemic prevention and control.
Post time: Apr-26-2022